PRE-AND POST-TREATMENT INDICATIONS IN CHRONIC HEART FAILURE WITH VARIOUS COMORBID DISEASES
Main Article Content
Abstract
120 patients with SYuE under observation were divided into three groups based on their comorbid diseases, all patients received 25-50 mg of the standard treatment of SYuE, β-blockers, azilsartan as an angiotensin II receptor antagonist, and eplerenone, the last generation of MKRA, as an antifibrotic agent. Six-minute walk test, clinical status rating scale, and Minnesota Questionnaire scores were analyzed before and after treatment in chronic heart failure with various comorbidities.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Gadaev, A. G., Turaqulov, R. I., Kurbonov, A. K., Tosheva, K. B., Erkinova, N. A., Xalilova, F. A., & Djuraeva, N. D. (2019). PRINCIPLES OF TREATMENT OF ANEMIA WITH CHRONIC HEART FAILURE. Toshkent tibbiyot akademiyasi axborotnomasi, (2), 18-21.
Гадаев, А. Г., Халилова, Ф. А., Элмурадов, Ф. Х., & Тошева, Х. Б. (2018). Структурно-функциональные изменения почек и сердца у больных ХСН. Терапевтический вестник, (1), 100-104.
Usmonov, I., & Shukurov, U. (2021). Features of the Clinical Course, the State of Diagnosis and Treatment of Hiv-Associated Pulmonary Tuberculosis in Modern Conditions Literature Review. Annals of the Romanian Society for Cell Biology, 1809-1828.
Usmonov, I. X., & Kobilov, N. Y. (2021). Epidemiology, Clinical Course, Diagnosis and Treatment of Generalized Tuberculosis in Modern Circumstances Literature Review. Annals of the Romanian Society for Cell Biology, 3806-3819.
Х, У.И., Муаззамов, Б.Р., и Джумаев, М.Ф. (2021). Особенности диагностики и лечения лекарственно-устойчивых форм туберкулеза легких. Международный журнал фармацевтических исследований , 13 (1), 2484-2489.
Erkinova, N. (2021). OBSERVATION OF ALBUMINURIA IN CHRONIC HEART FAILURE AND SOME OF ITS CLINICAL FEATURES. Galaxy International Interdisciplinary Research Journal, 9(05), 442-446.
Nigora, E., & Nargiza, X. (2021). OBSERVATIONS, CLINICAL FEATURES OF ALBUMINURIA WITH RENAL CHANGES IN CHRONIC HEART FAILURE. Academicia Globe: Inderscience Research, 2(05), 335-339.
Erkinovna, E. N., & Ulugbekovna, О. А. (2021, August). THE COURSE OF COMORBID CONDITIONS IN DIFFERENT FUNCTIONAL CLASSES OF CHRONIC HEART FAILURE. In INTERNATIONAL CONFERENCE ON MULTIDISCIPLINARY RESEARCH AND INNOVATIVE TECHNOLOGIES (Vol. 1, pp. 131-134).
Bekmurodovna, T. K., & Gadaevich, G. A. (2021). Dynamics of Renal Fibrosis Markers on the Basis of Complex Treatment in Chronic Heart Failure with Anemia.
Tosheva, K. B. (2022). PRINCIPLES OF TREATMENT OF ANEMIA WITH CHRONIC HEART FAILURE. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 2(9), 33-37.
Тошева, Х. Б., & Кенжаева, З. О. (2014). Пропаганда здорового образа жизни в селе как механизм сохранения здоровья сельского населения.
Рахмонова, К. М. (2022). Разработка Методов Ранней Диагностики, Лечения И Профилактики Хронической Дыхательной Недостаточности При Туберкулёзе Легких (Обзорная Литературы). CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 3(3), 262-272.
Mizrobovna, R. K. (2022). Accompanying Diseases of the Respiratory System Pulmonary Tuberculosis. European Multidisciplinary Journal of Modern Science, 4, 244-250.
Erkinova, N. (2021). OBSERVATION OF ALBUMINURIA IN CHRONIC HEART FAILURE AND SOME OF ITS CLINICAL FEATURES. Galaxy International Interdisciplinary Research Journal, 9(05), 442-446.